Prurigo nodularis
- 23 May 2020
- journal article
- research article
- Published by Elsevier BV in Journal of the American Academy of Dermatology
- Vol. 83 (6), 1567-1575
- https://doi.org/10.1016/j.jaad.2020.04.182
Abstract
No abstract availableKeywords
Funding Information
- Skin of Color Society
- Pfizer
- Kiniksa Pharmaceuticals
This publication has 55 references indexed in Scilit:
- Thalidomide in 42 Patients with Prurigo Nodularis HydeDermatology, 2011
- Reduced intraepidermal nerve fibre density in lesional and nonlesional prurigo nodularis skin as a potential sign of subclinical cutaneous neuropathyBritish Journal of Dermatology, 2011
- An occlusive dressing containing betamethasone valerate 0.1% for the treatment of prurigo nodularisJournal of Dermatological Treatment, 2010
- Targeting the Neurokinin Receptor 1 with Aprepitant: A Novel Antipruritic StrategyPLOS ONE, 2010
- Prurigo nodularis: systematic analysis of 58 histological criteria in 136 patientsJournal of Cutaneous Pathology, 2010
- Antipruritic effect of cyclosporine microemulsion in prurigo nodularis: Results of a case seriesJDDG: Journal der Deutschen Dermatologischen Gesellschaft, 2008
- Biologic agents in psoriasisAustralasian Journal of Dermatology, 2006
- Butorphanol for treatment of intractable pruritusJournal of the American Academy of Dermatology, 2006
- Prurigo nodularis: A reviewAustralasian Journal of Dermatology, 2005
- Histamine‐containing mast cells and their relationship to NGFr‐immunoreactive nerves in prurigo nodularis: a reappraisalJournal of Cutaneous Pathology, 1998